Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $5.97 USD
Change Today -0.12 / -1.97%
Volume 810.6K
SPPI On Other Exchanges
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rajesh C. Shrotriya M.D.

Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee, Spectrum Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Rajesh C. Shrotriya, M.D., has been the Chairman and Chief Executive Officer of Spectrum Pharmaceuticals, Inc. since August 2002 and served as its President from September 2000 to April 17, 2014. From September 2000 to August 2002, Dr. Shrotriya served as the Chief Operating Officer of Spectrum. He served as an Executive Vice President and Chief Scientific Officer for SuperGen, Inc. from November 1996 to August 2000 and its Senior Vice President and Special Assistant ...

Read Full Background

Corporate Headquarters*

11500 South Eastern Avenue
Henderson, Nevada 89052

United States

Phone: 702-835-6300
Fax: 702-260-7405

Board Members Memberships*

Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Former Director, Member of Governance & Nominating Committee and Member of Compensation Committee


Bachelor's Degree
Armed Forces Medical College, Pune
BS 1962
Aligarh Muslim University
MD 1974
Grant Medical College Bombay
Postgraduate Diploma 1971
University of Delhi

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,800,000

Stock Options*

Restricted Stock Awards$734,400
All Other Compensation$167,508
Exercised Options403,948
Exercised Options Value$1,566,199
Exercisable Options4,844,021
Exercisable Options Value$16,315,309
Unexercisable Options1,344,833
Unexercisable Options Value$567,500
Total Value of Options$18,449,008
Total Number of Options6,592,802

Total Compensation*

Total Annual Cash Compensation$1,967,508
Total Short Term Compensation$1,800,000
Other Long Term Compensation$901,908
Total Calculated Compensation$5,631,565
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SPPI:US $5.97 USD -0.12


James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
Amr Mamdouh Abdel Majid Chairman of the Board and Managing Director
GlaxoSmithKline S.A.E
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SPECTRUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at